Search contract descriptions, companies and agencies.
UNIVERSITY OF CHICAGO, THE
Total Committed Value of Federal Contracts
$10.2M
Recent Contract Actions
Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.
| Description |
Category |
Agency |
Signed |
Amount Committed |
| MEDICAL IMAGING AND DATA RESOURCE CENTER (MIDRC)FOR RAPID RESPONSE TO COVID-19 PANDEMIC |
Biomedical Applied Research/Exploratory Development R&D |
National Institutes of Health |
March 09, 2021 |
-$155,424 |
| MEDICAL IMAGING AND DATA RESOURCE CENTER (MIDRC) FOR RAPID RESPONSE TO COVID-19 PANDEMIC |
Biomedical Applied Research/Exploratory Development R&D |
National Institutes of Health |
March 09, 2021 |
$0 |
| MEDICAL IMAGING AND DATA RESOURCE CENTER (MIDRC) FOR RAPID RESPONSE TO COVID-19 PANDEMIC |
Biomedical Applied Research/Exploratory Development R&D |
National Institutes of Health |
August 21, 2020 |
$0 |
| MEDICAL IMAGING AND DATA RESOURCE CENTER (MIDRC) FOR RAPID RESPONSE TO COVID-19 PANDEMIC |
Biomedical Applied Research/Exploratory Development R&D |
National Institutes of Health |
August 21, 2020 |
$0 |
| MEDICAL IMAGING AND DATA RESOURCE CENTER (MIDRC)FOR RAPID RESPONSE TO COVID-19 PANDEMIC |
Biomedical Applied Research/Exploratory Development R&D |
National Institutes of Health |
August 21, 2020 |
$9,500,000 |
| MEDICAL IMAGING AND DATA RESOURCE CENTER (MIDRC) FOR RAPID RESPONSE TO COVID-19 PANDEMIC |
Biomedical Applied Research/Exploratory Development R&D |
National Institutes of Health |
August 21, 2020 |
$0 |
| MEDICAL IMAGING AND DATA RESOURCE CENTER (MIDRC) FOR RAPID RESPONSE TO COVID-19 PANDEMIC |
Biomedical Applied Research/Exploratory Development R&D |
National Institutes of Health |
August 04, 2020 |
$500,000 |
| COVID-19. TO IDENTIFY NOVEL ADJUVANT CANDIDATES THAT CAN BE USED TO AUGMENT THE EFFICACY OF HUMAN VACCINES. |
Biomedical R&D |
National Institutes of Health |
June 16, 2020 |
$319,510 |
About this data
This data comes from the
Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the
procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a
90-day delay before it appears in the data.
